Your browser doesn't support javascript.
loading
Development of an UPSA Short Form for Use in Longitudinal Studies in the Early Alzheimer's Disease Spectrum.
Goldberg, T E; Harvey, P D; Devanand, D P; Keefe, R S E; Gomar, J J.
Afiliação
  • Goldberg TE; Dr. Jesus J. Gomar, Litwin-Zucker Alzheimer's Disease Center, Feinstein Institute, Manhassett, NY, USA, Email: jgomar@northwell.edu, Telephone: 516-562-0420, Fax: 516-562-0401.
J Prev Alzheimers Dis ; 7(3): 179-183, 2020.
Article em En | MEDLINE | ID: mdl-32463071
ABSTRACT

BACKGROUND:

In individuals with only mild or very mild cognitive attenuations (i.e., so-called pre-clinical AD), performance-based measures of function may be superior to informant-based measures because of increased sensitivity, greater reliability, and fewer ceiling effects.

OBJECTIVE:

We sought to determine if a performance-based measure of everyday function would demonstrate adequate psychometric properties and validity in the context of serial assessment over a one-year period in patients with Mild Cognitive Impairment (MCI) and early stage Alzheimer's disease (AD).

DESIGN:

Participants were assessed with the performance-based measure at baseline, six weeks, and one year.

SETTING:

A specialized center for the assessment and treatment of AD.

PARTICIPANTS:

Three groups of subjects participated a healthy subjects (HS) older cognitively intact group (N=43), an MCI group (N=20), and an AD group (N=26). MEASUREMENTS A three subtest short form of the UCSD Performance-Based Skills Assessment (UPSA) (called the UPSA-3) was the measure of interest. It consisted of the Communication, Planning, and Finance subtests.

RESULTS:

Mixed model repeated measures were used to assess performance over time. Large group effects were present (HS>MCI>AD). Additionally, the AD and MCI groups demonstrated declines over one year, while the HS group remained stable (group x time interaction p=.11). The MCI/AD group demonstrated adequate test-retest reliability and did not demonstrate ceiling or floor effects.

CONCLUSION:

Our data indicate that the UPSA-3 is suitable for clinical trials in that it has adequate ecological coverage and reasonable psychometric properties, and perhaps most importantly, demonstrates validity in serial assessments.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Desempenho Psicomotor / Doença de Alzheimer / Disfunção Cognitiva / Testes de Estado Mental e Demência Tipo de estudo: Observational_studies / Prognostic_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Desempenho Psicomotor / Doença de Alzheimer / Disfunção Cognitiva / Testes de Estado Mental e Demência Tipo de estudo: Observational_studies / Prognostic_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article